COVID-19 outbreak has challenged the way many businesses are conducting their activities, including those as essential as signing. With no opportunities to sign agreements on paper physically in the era of physical distancing but still pressing needs to sign contracts such as medical consents for COVID-19 testing or patient intake forms, DocuSign has come to the rescue with its ecosystem of electronic signatures processing. However, if the company succeeds with its mission of universal use of electronic signatures as new normal, would it be able to defend its positions in the market, or would its services become commoditized or performed better by other tech giants?